Long-term survival of a stage 4 neuroblastoma patient despite persistent bone marrow disease following autologous bone marrow transplantation
- 23 December 1999
- journal article
- case report
- Published by Wiley in Medical and Pediatric Oncology
- Vol. 33 (6) , 585-587
- https://doi.org/10.1002/(sici)1096-911x(199912)33:6<585::aid-mpo13>3.0.co;2-y
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor Registry.Journal of Clinical Oncology, 1998
- A population-based study of the usefulness of screening for neuroblastomaThe Lancet, 1996
- Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children's Cancer Group studies.Journal of Clinical Oncology, 1996
- Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.Journal of Clinical Oncology, 1993
- Continued Remission in Children with Neuroblastoma Despite Elevations of Urinary Catecholamine MetabolitesJournal of Pediatric Hematology/Oncology, 1992
- Histopathologic Prognostic Factors in Neuroblastic Tumors: Definition of Subtypes of Ganglioneuroblastoma and an Age-Linked Classification of NeuroblastomasJNCI Journal of the National Cancer Institute, 1984
- Ganglioneuroma presenting with differentiated skeletal metastases. Report of a caseCancer, 1984
- SPECIAL PATTERN OF WIDESPREAD NEUROBLASTOMA WITH A FAVOURABLE PROGNOSISThe Lancet, 1971